RCT proves higher survival with Impella in cardiogenic shock.

RCT Proves Higher Survival With Impella in Cardiogenic Shock

The DanGer Shock RCT Found That Routine Use of Impella CP® Reduces All-Cause Mortality at 180 Days in AMI Cardiogenic Shock Due to STEMI Compared to Standard Care1
 

DanGer Shock Results from Dr. Jacob Møller at ACC 2024

Jacob Møller, MD, the principal investigator of the DanGer Shock trial, discusses study results he presented at ACC 2024.

Sign up for Latest HeartRecovery Updates

Register for our newsletter and stay tuned for latest news about Impella devices, clinical evidence and events.

The Heart of the Matter The Heart of the Matter

The Heart of the Matter: Best Practice Approach on High-Risk Percutaneous Coronary Intervention

“The Heart of the Matter: Best practice approach on high-risk percutaneous coronary intervention” is a publication of eight articles addressing patient management and mechanical circulatory support (MCS) related to protected, high-risk percutaneous coronary intervention (PCI).

Native Heart and Lung Recovery

Conditions & Therapies

Access education, clinical evidence and practice support for Protected PCI, AMI cardiogenic shock, right heart failure, surgical applications and severe lung failure.

Products & Services

Learn about the latest technology and how that technology may best support your patient.

Education & Resources

Abiomed provides a comprehensive training program for health care providers.

Joint EAPCI/ACVC Expert Consensus Document

on percutaneous ventricular assist devices

References

  1. Møller, J., et al. (2024). Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. N Engl J Med.

NPS-2641

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].